Is Retinalamin FDA approved?
No. This profile records Retinalamin as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Longevity CATEGORY
Retinalamin
THE RETINA REGENERATOR
Retinal Peptide Complex A-17
Retinalamin is a peptide complex derived from retinal tissue specifically designed to support eye health. It promotes regeneration of retinal neurons and pigment epithelium, enhances blood flow to the retina, and protects photoreceptors from oxidative damage. It's used clinically for macular degeneration, diabetic retinopathy, and optic nerve conditions.
Retinalamin
Retinalamin
Retinalamin
Retinalamin Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
May 8, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About Retinalamin
What dose does The Peptide App Clinical Team recommend for Retinalamin?
Dose: 5-10 mg intramuscularly or parabulbarly daily for 10 days.
MORE CONTEXT ›
Schedule: daily. Cycle: Repeat every 4-6 months. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this Retinalamin guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
Gene Modulation
Gene Modulation
Microcirculation
Improves blood flow to retinal tissue
Photoreceptor Protection
Stabilizes photoreceptor membranes
BDNF Production
Promotes neuroprotective factors in retina
Those with age-related macular degeneration
People with diabetic retinopathy
Anyone with retinitis pigmentosa
Those recovering from retinal damage
People wanting to protect long-term vision
Retinalamin Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES